Tilray Inc buy PlusUltra
Summary
This prediction ended on 15.09.22 with a price of €3.35. Massive losses of -63.46% were the result for the BUY prediction by PlusUltra. This prediction was marked as speculative and is excluded from PlusUltra's performance statistics.Tilray, Inc. is a Canadian-based pharmaceutical and cannabis company that is listed on the NASDAQ exchange under the ticker symbol TLRY. The company specializes in the research, cultivation, production, and distribution of medical cannabis products worldwide. Founded in 2013, Tilray has become one of the largest cannabis companies in the world with operations in North America, Europe, and Australia. The company's main areas of focus are medical research and development, consumer brands, as well as global distribution partnerships. As a publicly traded company, Tilray's stock price is subject to market fluctuations and investor sentiment towards the cannabis industry.
Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Tilray Inc | -14.105% | -14.105% | -78.620% |
iShares Core DAX® | -1.114% | 5.062% | 24.922% |
iShares Nasdaq 100 | 1.816% | 9.828% | 29.548% |
iShares Nikkei 225® | 2.113% | 8.218% | 22.231% |
iShares S&P 500 | 2.038% | 7.448% | 30.358% |
According to PlusUltra what are the pros and cons of Tilray Inc for the foreseeable future?
Pros
Cons
Comments by PlusUltra for this prediction
In the thread Tilray Inc diskutieren
Stopped prediction by PlusUltra for Tilray Inc
Tilray Inc
03.10.21
03.10.22
01.11.21
Tilray Inc
09.02.21
09.02.22
03.10.21